Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe De Block

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Diabetes, Obesity & Metabolism|August 17, 2021
Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoringLisa Billion, Sara Charleer, Laurens Verbraeken, et al.
Transplantation|October 26, 2016
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune SuppressionDaHae Lee, Bart Keymeulen, Robert Hilbrands, et al.
Diabetes, Obesity & Metabolism|August 28, 2024
Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONENele Steenackers, Thomas Sparsø, Sara Charleer, et al.
Eclinicalmedicine|March 18, 2024
Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trialCaro Minschart, Nele Myngheer, Toon Maes, et al.
Diabetes Care|March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)David Russell-Jones, Bruce W Bode, Christophe De Block, et al.
European Journal of Endocrinology|April 25, 2014
Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's diseaseSusan M Webb, John E Ware, Anna Forsythe, et al.
Diabetologia|January 18, 2024
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in BelgiumMargaretha M Visser, Astrid Van Muylder, Sara Charleer, et al.
Diabetes Care|October 17, 2020
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE StudySara Charleer, Christophe De Block, Frank Nobels, et al.
Diabetes, Obesity & Metabolism|March 10, 2026
The One-Hour Oral Glucose Tolerance Test to Predict Glucose Intolerance Postpartum in Women With Prior Gestational DiabetesNiels Bochanen, Yana Vanlaer, Caro Minschart, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2026
Treatment adherence and satisfaction of a mobile-based lifestyle intervention in women with prior gestational diabetesYana Vanlaer, Caro Minschart, Fien Reyns, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Diabetes, Obesity & Metabolism|August 17, 2021
Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoringLisa Billion, Sara Charleer, Laurens Verbraeken, et al.
Transplantation|October 26, 2016
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune SuppressionDaHae Lee, Bart Keymeulen, Robert Hilbrands, et al.
Diabetes, Obesity & Metabolism|August 28, 2024
Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONENele Steenackers, Thomas Sparsø, Sara Charleer, et al.
Eclinicalmedicine|March 18, 2024
Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trialCaro Minschart, Nele Myngheer, Toon Maes, et al.
Diabetes Care|March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)David Russell-Jones, Bruce W Bode, Christophe De Block, et al.
European Journal of Endocrinology|April 25, 2014
Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's diseaseSusan M Webb, John E Ware, Anna Forsythe, et al.
Diabetologia|January 18, 2024
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in BelgiumMargaretha M Visser, Astrid Van Muylder, Sara Charleer, et al.
Diabetes Care|October 17, 2020
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE StudySara Charleer, Christophe De Block, Frank Nobels, et al.
Diabetes, Obesity & Metabolism|March 10, 2026
The One-Hour Oral Glucose Tolerance Test to Predict Glucose Intolerance Postpartum in Women With Prior Gestational DiabetesNiels Bochanen, Yana Vanlaer, Caro Minschart, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2026
Treatment adherence and satisfaction of a mobile-based lifestyle intervention in women with prior gestational diabetesYana Vanlaer, Caro Minschart, Fien Reyns, et al.
Pageof 15